Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
Tags
boston blog main
6
×
drugs
6
×
life sciences
national blog main
new york blog main
new york top stories
pfizer
6
×
boston top stories
clinical trials
national top stories
san diego blog main
san diego top stories
biotech
boulder/denver blog main
boulder/denver top stories
fda
san francisco blog main
san francisco top stories
abbvie
cancer
detroit blog main
detroit top stories
indiana blog main
indiana top stories
investing
national
raleigh-durham blog main
raleigh-durham top stories
seattle blog main
seattle top stories
startups
texas blog main
texas top stories
wisconsin blog main
wisconsin top stories
akcea therapeutics
astrazeneca
bristol-myers squibb
cancer immunotherapy
celgene
What
drug
fda
alnylam
annual
approved
bio
conference
disease
europe
roundup
ago
akcea
alzheimer’s
american
amyloidosis
approves
ash
assessed
attention
attr
available
babies
battle
biotech
birth
blood
born
borne
breastfeed
cancers
cells
communities
companies
days
debilitating
diego
digital
ema
employ
epidemic
Language
Current search:
pfizer
×
drugs
×
" boston blog main "
×
@xconomy.com
4 years ago
PanTheryx Lands $50M to Use “First Milk” to Target Gut Microbiome
@xconomy.com
5 years ago
FDA OKs Pfizer Rare Disease Drug, Sets Up Battle With Alnylam, Akcea
@xconomy.com
5 years ago
Bio Roundup: NASH News, Merck Strikes, Digital Tokens & More
@xconomy.com
5 years ago
ASH 2018: A Guide to the Latest for Blood-Borne Cancers and More
@xconomy.com
5 years ago
Bio Roundup: Alzheimer’s Puzzle, ESMO Assessed, Drug Prices & More
@xconomy.com
5 years ago
RNAi Hits Europe as EMA Follows FDA, Approves Alnylam Drug